Aurora Cannabis (ACB) announced it has made a big move into the U.S. market via its acquisition of Reliva, LLC, one of the major players in America.The company said the at close the deal will be “immediately accretive to shareholders on an adjusted EBITDA basis.”In this article we’ll look at some of the strengths the two companies will complement each…
Most Canadian licensed producers are likely sitting on underutilized or unused assets that they won’t be able to move. READ MORE: https://finance.yahoo.com/m/5ad06ae0-70c3-3499-96c9-7210ef25a603/aurora-cannabis%26%2339%3B-exeter.html?.tsrc=rss
Reliva had been trying to raise venture-capital money at a $40 million valuation before taking that amount in Aurora stock for acquisition The courtship between Aurora Cannabis Inc. and Reliva began, as many such romances do, at a gathering of industry bigwigs and bankers. It was not quite love at first sight. Well ahead of the first meeting at…
The company’s revenue was an improvement from the previous quarter, but Aurora still posted a loss. READ MORE: https://finance.yahoo.com/m/4e81ad1d-0af6-3385-bf6f-6feb0007eae9/is-aurora-cannabis-a-buy.html?.tsrc=rss
The courtship between Aurora Cannabis Inc. and Reliva began, as many such romances do, at a gathering of industry bigwigs and bankers. It was not quite love at first sight. READ MORE: https://finance.yahoo.com/m/b2f731d8-52a7-3a9f-ac3a-e51afc33000f/inside-the-aurora-cannabis.html?.tsrc=rss
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better…
As a result, many investors are increasingly looking for stability in a volatile stock market. One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). Aurora posted a string of poor financial performances last year and earlier in 2020. READ MORE: https://finance.yahoo.com/m/3fba3327-e35f-3802-a616-92a737f0d114/why-is-everyone-talking-about.html?.tsrc=rss
Aurora Cannabis’s (NYSE: ACB) stock has been wildly fluctuating since the release of its better-than-expected Q3 earnings report May 14 in which the company acknowledged $53.8 million in sales. First, Aurora’s stock had an unusually strong day, surging upwards of 70% on Monday. Aurora may soon try to frame its favorable Q3 earnings as a hard-fought success in a market…
The courtship between Aurora Cannabis Inc. and Reliva began, as many such romances do, at a gathering of industry bigwigs and bankers. It was not quite love at first sight. READ MORE: https://finance.yahoo.com/m/b2f731d8-52a7-3a9f-ac3a-e51afc33000f/inside-the-aurora-cannabis.html?.tsrc=rss
Shares of Aurora Cannabis (NYSE: ACB) sank 6.6% on Friday after analysts at Jefferies downgraded the popular marijuana stock. Jefferies lowered its rating on Aurora’s stock from hold to underperform. The investment bank says the recent surge in Aurora’s share price is too much, too fast. READ MORE: https://finance.yahoo.com/m/23f0c589-3f1f-31a5-a761-105921e95b3d/why-aurora-cannabis-stock.html?.tsrc=rss
Jefferies analyst Owen Bennett downgraded marijuana stock Aurora to Underperform, saying it faces headwinds. Aurora shares had recently nearly tripled. READ MORE: https://finance.yahoo.com/m/54be2145-476d-373c-bd7a-c47be29fbdc9/aurora-cannabis-stock-is.html?.tsrc=rss
For years, there was no hotter investment on the planet than marijuana stocks. Regulatory-based supply issues in Canada, stubbornly high tax rates in the U.S., and financing concerns throughout North America have haunted the industry and sent pot stock valuations tumbling. Arguably the biggest disappointment of all has been Aurora Cannabis (NYSE: ACB). READ MORE: https://finance.yahoo.com/m/58440dbd-d34d-36d1-9e18-936baf8de8a1/aurora-cannabis-finally.html?.tsrc=rss